Opposing effects of Nrf2 and Nrf2-activating compounds on the NLRP3 inflammasome independent of Nrf2-mediated gene expression
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
The transcription factor Nrf2 regulates the expression of genes required for protection from xenobiotic and oxidative stress. Under normal conditions Nrf2 is constantly degraded upon ubiquitination, mediated by the Nrf2 inhibitor Keap1. Inflammasomes represent stress‐induced protein complexes. They are critically involved in acute and chronic inflammation through caspase‐1‐mediated activation of pro‐inflammatory cytokines. Here, we demonstrate that Nrf2 is a positive regulator of the NLRP3 inflammasome. In contrast, Nrf2‐activating compounds, including the anti‐inflammatory drug dimethyl fumarate (DMF), inhibit inflammasome activation. Both effects are independent of the transcriptional activity of Nrf2 and, at least in part, not interdependent. On the other hand, NLRP3 inflammasome activation induces a rapid and partly caspase‐1‐ and Keap1‐independent degradation of Nrf2. These data argue against a simultaneous activation of both stress‐related pathways. Finally, we provide evidence that the cross‐regulation of both pathways is controlled by a physical interaction between the Nrf2/Keap1 and NLRP3 complexes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Numerous studies have suggested that Nrf2 activators such as melatonin and natural compounds inhibit NLRP3 inflammasome activation (31, 32).”
From Melatonin Attenuates LPS-Induced Acute Depressive-Like Behaviors and Microglial NLRP3 Inflammasome Activation Through the SIRT1/Nrf2 Pathway (2019) · cites this paper as [32]
In the citing paper
“Numerous studies have suggested that Nrf2 activators such as melatonin and other natural compounds inhibit NLRP3 inflammasome via suppressing ROS production (6, 32).”
From Melatonin Attenuates LPS-Induced Acute Depressive-Like Behaviors and Microglial NLRP3 Inflammasome Activation Through the SIRT1/Nrf2 Pathway (2019) · cites this paper as [32]
Citations
Cites
Schroder, K., & Tschopp, J. (2010) · Cell · doi:10.1016/j.cell.2010.01.040 · Cited by 5,475
Gout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326
Improved vectors and genome-wide libraries for CRISPR screening
Sanjana, N. E., Shalem, O., & Zhang, F. (2014) · Nature Methods · doi:10.1038/nmeth.3047 · Cited by 5,239
Cell Survival Responses to Environmental Stresses Via the Keap1-Nrf2-ARE Pathway
Kensler, T. W., Wakabayashi, N., & Biswal, S. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141046 · Cited by 3,630
Immunological and inflammatory functions of the interleukin-1 family
Dinarello, C. A. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132612 · Cited by 3,466
Inflammasomes in health and disease
Strowig, T., Henao-Mejia, J., Elinav, E., & Flavell, R. (2012) · Nature · doi:10.1038/nature10759 · Cited by 2,230
Conditional gene targeting in macrophages and granulocytes using LysMcre mice
Clausen, B. E., Burkhardt, C., Reith, W., Renkawitz, R., & Förster, I. (1999) · Transgenic Research · doi:10.1023/a:1008942828960 · Cited by 2,098
Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription
Kobayashi, E. H., Suzuki, T., Funayama, R., Nagashima, T., Hayashi, M., Sekine, H., Tanaka, N., Moriguchi, T., Motohashi, H., Nakayama, K., et al. (2016) · Nature Communications · doi:10.1038/ncomms11624 · Cited by 1,878
Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution
Taguchi, K., Motohashi, H., & Yamamoto, M. (2011) · Genes to Cells · doi:10.1111/j.1365-2443.2010.01473.x · Cited by 1,478
The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer
Kansanen, E., Kuosmanen, S. M., Leinonen, H., & Levonen, A.-L. (2013) · Redox Biology · doi:10.1016/j.redox.2012.10.001 · Cited by 1,313
Cited by
The Immunomodulatory Metabolite Itaconate Modifies NLRP3 and Inhibits Inflammasome Activation
Hooftman, A., Angiari, S., Hester, S., Corcoran, S. E., Runtsch, M. C., Ling, C., Ruzek, M. C., Slivka, P. F., McGettrick, A. F., Banahan, K., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.07.016 · Cited by 609
“, 2018), leading to activation of NRF2, a protein that is thought to regulate NLRP3 inflammasome activation (Garstkiewicz et al., 2017; Zhao et al., 2014).”
BackgroundArioz, B. I., Tastan, B., Tarakcioglu, E., Tufekci, K. U., Olcum, M., Ersoy, N., Bagriyanik, A., Genc, K., & Genc, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01511 · Cited by 516
“Numerous studies have suggested that Nrf2 activators such as melatonin and natural compounds inhibit NLRP3 inflammasome activation (31, 32).”
BackgroundBruton’s Tyrosine Kinase: An Emerging Key Player in Innate Immunity
Weber, A. N. R., Bittner, Z., Liu, X., Dang, T.-M., Radsak, M. P., & Brunner, C. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01454 · Cited by 269
“Whether BTK also plays a role in the alternative NLRP3 inflammasome dependent on caspase-11 remains to be investigated.”
BackgroundInfluentialThe Crosstalk between Nrf2 and Inflammasomes
Hennig, P., Garstkiewicz, M., Grossi, S., Di Filippo, M., French, L., & Beer, H.-D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020562 · Cited by 253
“It is likely that this loop is more relevant before than after inflammasome assembly, since Nrf2 is quickly degraded upon inflammasome activation [63].”
BackgroundInfluentialSelf-citationLoop Between NLRP3 Inflammasome and Reactive Oxygen Species
Dominic, A., Le, N.-T., & Takahashi, M. (2022) · Antioxidants & Redox Signaling · doi:10.1089/ars.2020.8257 · Cited by 242
“(25) recently reported interesting results that Nrf2 is a positive regulator of the NLRP3 in-flammasome, whereas Nrf2-activating compounds inhibit NLRP3 inflammasome activation.”
Sharma, A., Tate, M., Mathew, G., Vince, J. E., Ritchie, R. H., & de Haan, J. B. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00114 · Cited by 215
“It is important to note that there is a caveat to modulating Nrf2, as endogenous Nrf2 in certain situations has been shown to be a positive regulator of the NLRP3 inflammasome (Zhao et al., 2014; Garstkiewicz et al., 2017) and Nrf2 deficient mice on an ApoE-deficient background are protected against atherogenesis (Fre…”
BackgroundActivation of Nrf2 signaling by natural products-can it alleviate diabetes?
Matzinger, M., Fischhuber, K., & Heiss, E. H. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2017.12.015 · Cited by 204
Hsu, C. G., Chávez, C. L., Zhang, C., Sowden, M., Yan, C., & Berk, B. C. (2022) · Cell Death & Differentiation · doi:10.1038/s41418-022-00966-5 · Cited by 168
“Nrf2, an antioxidant transcription factor, has been proposed to regulate NLRP3 105 inflammasome activation (30-32).”
BackgroundNrf2-Mediated Fibroblast Reprogramming Drives Cellular Senescence by Targeting the Matrisome
Hiebert, P., Wietecha, M. S., Cangkrama, M., Haertel, E., Mavrogonatou, E., Stumpe, M., Steenbock, H., Grossi, S., Beer, H.-D., Angel, P., et al. (2018) · Developmental Cell · doi:10.1016/j.devcel.2018.06.012 · Cited by 165
Self-citationKosuru, R., Kandula, V., Rai, U., Prakash, S., Xia, Z., & Singh, S. K. (2018) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-018-6780-3 · Cited by 130
“mediated independently of Nrf2 target gene expression, but rather by physical interaction of Nrf2 with caspase-1 through Keap1/Cul3/Rbx1 components [63].”
BackgroundLiu, Q., Lv, H., Wen, Z., Ci, X., & Peng, L. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01518 · Cited by 116
Bai, Z., Liu, W., He, D., Wang, Y., Yi, W., Luo, C., Shen, J., & Hu, Z. (2020) · Aging · doi:10.18632/aging.103109 · Cited by 96
6-Gingerol ameliorates sepsis-induced liver injury through the Nrf2 pathway
Hong, M., Hu, L., Zhang, Y.-X., Xu, Y., Liu, X., He, P., & Jia, Y. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106196 · Cited by 92
The Multifaceted Roles of NRF2 in Cancer: Friend or Foe?
Glorieux, C., Enriquez-Lara, C., González, C. D., Aguirre-Martínez, G. V., & Calderón, P. B. (2024) · Antioxidants · doi:10.3390/antiox13010070 · Cited by 103
“Interestingly, inflammasome activation leads to rapid degradation of NRF2 by an as-yet-unknown mechanism [136].”
BackgroundShi, L., Zhang, S., Huang, Z., Hu, F., Zhang, T., Wei, M., Bai, Q., Lü, B., & Ji, L. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.05.012 · Cited by 90
Nrf2 as a therapeutic target for rheumatic diseases
Ferrándiz, M. L., Nácher-Juan, J., & Alcaraz, M. J. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.04.010 · Cited by 77
Regulation of innate immunity by Nrf2
van der Horst, D., Carter-Timofte, M. E., van Grevenynghe, J., Laguette, N., Dinkova‐Kostova, A. T., & Olagnier, D. P. (2022) · Current Opinion in Immunology · doi:10.1016/j.coi.2022.102247 · Cited by 77
Hoyle, C., Green, J., Allan, S. M., Brough, D., & Lemarchand, E. (2022) · Immunology · doi:10.1111/imm.13454 · Cited by 72
“We demonstrate that DMF, an approved clinical treatment for relapsing– remitting multiple sclerosis [49,59,60] and psoriasis [61], was an effective NLRP3 inhibitor in both macrophages and microglia, as has been suggested previously [26,27,62].”
BackgroundRahim, I., Sayed, R. K. A., Fernández‐Ortiz, M., Aranda‐Martínez, P., Guerra‐Librero, A., Fernández‐Martínez, J., Rusanova, I., Escames, G., Djerdjouri, B., & Acuña-Castroviejo, D. (2020) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-020-01972-5 · Cited by 61
An Epigenetic Insight into NLRP3 Inflammasome Activation in Inflammation-Related Processes
Raneros, A. B., Bernet, C. R., Flórez, A. B., & Suárez-Álvarez, B. (2021) · Biomedicines · doi:10.3390/biomedicines9111614 · Cited by 53
“On one hand, it functions as a positive regulator of NLRP3 inflammasome activation [98].”
Wang, H., Lv, J., Jiang, N., Huang, H. M., Wang, Q., & Liu, X. (2021) · Phytotherapy Research · doi:10.1002/ptr.6947 · Cited by 50
Kar, S., Kambis, T. N., & Mishra, P. K. (2019) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00004.2019 · Cited by 50
NLRP3: a new therapeutic target in alcoholic liver disease
Brahadeeswaran, S., Dasgupta, T., Manickam, V., Saraswathi, V., & Tamizhselvi, R. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1215333 · Cited by 52
Dwivedi, D. K., Jena, G., & Kumar, V. (2020) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22476 · Cited by 52
Islam, M. T., Bardaweel, S. K., Mubarak, M. S., Koch, W., Gaweł‐Bęben, K., Antosiewicz, B., & Sharifi‐Rad, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.572136 · Cited by 45
Immunomodulatory effects of 4-hydroxynonenal
Ioannidis, M., Tjepkema, J., Uitbeijerse, M. R. P., & van den Bogaart, G. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103719 · Cited by 50
“Moreover, the inflammasome is regulated by transcription factors that are affected by 4-HNE, including Nrf2 [84] and NF-κ B [36].”
Regulation of NLRPs by reactive oxygen species: A story of crosstalk
Ziehr, B. K., & MacDonald, J. A. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2024.119823 · Cited by 49
Dimethyl fumarate accelerates wound healing under diabetic conditions
Li, Y., Ma, F., Li, H., Yu-guo, S., Zhang, H., Jiang, Z., & Wu, H. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0102 · Cited by 39
Development of covalent NLRP3 inflammasome inhibitors: Chemistry and biological activity
Bertinaria, M., Gastaldi, S., Marini, E., & Giorgis, M. (2018) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2018.11.013 · Cited by 40
“Moreover, a recent paper [129] demonstrated that Nrf2-induced gene expression is not involved in inflammasome regulation, while”
BackgroundCheng, Y., Liu, M., Tang, H., Chen, B., Yang, G., Zhao, W., Cai, Y., & Shang, H. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6630281 · Cited by 37
Jain, R., Vora, L. K., Nathiya, D., & Khatri, D. K. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05389-0 · Cited by 39
“Although studies have shown that Nrf2 and Nrf2-activating chemicals have opposing effects on the NLRP3 inflammasome that are not dependent on Nrf2-mediated gene expression, both effects are independent of the transcriptional activity of Nrf2 [129].”
Dwivedi, D. K., & Jena, G. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.11.100 · Cited by 33
Abo‐Youssef, A. M., Mohammad, M. K., Abo‐Saif, A. A., & Messiha, B. A. S. (2021) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2021.08.005 · Cited by 35
Electrophiles against (Skin) Diseases: More Than Nrf2
Hennig, P., Fenini, G., Filippo, M. D., & Beer, H. (2020) · Biomolecules · doi:10.3390/biom10020271 · Cited by 32
“In addition, NRF2 activators inhibit also the transcriptional activity of NF-κB and the inflammasome pathway (see below) [19,22].”
BackgroundInfluentialSelf-citationDwivedi, D. K., & Jena, G. (2021) · Inflammation · doi:10.1007/s10753-021-01571-3 · Cited by 32
Ruan, H., Li, W., Wang, J., Chen, G., Xia, B., Wang, Z., & Zhang, M. (2020) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2020.104427 · Cited by 31
Cuadrado, A., Cazalla, E., Bach, A., Bathish, B., Naidu, S. D., DeNicola, G. M., Dinkova-Kostova, A. T., Fernández-Ginés, R., Grochot-Przeczek, A., Hayes, J. D., et al. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103569 · Cited by 28
“NRF2 suppresses the transcription of NLRP3 inflammasome-associated genes, including those coding for NLRP3, proIL-1 β , and proIL-1 α [38,39]. p62 and PGAM5 are regulators of the NRF2/KEAP1 as well as the NLRP3 inflammasome pathways. p62 activates NRF2 [40] and antagonizes NLRP3 inflammasome…”
Wang, Y., Tang, Y., Gao, X. W., Liu, J., Zhang, N., Liang, Z., Li, Y., & Pan, L.-X. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.01.015 · Cited by 24
Nrf2 in the Field of Dentistry with Special Attention to NLRP3
Schieffer, L., Manzl, C., Schatz, C., Haybaeck, J., & Crismani, A. G. (2022) · Antioxidants · doi:10.3390/antiox11010149 · Cited by 22
“Moreover, Nrf2 has been demonstrated to directly suppress transcription of NLRP3associated genes, including pro-IL-1β, and pro-IL-1α [111,112], suggesting Nrf2 to be a potential therapeutic inhibitor of PD.”
BackgroundTranscription Factor NRF2 in Shaping Myeloid Cell Differentiation and Function
Pfefferlé, M., & Vallelian, F. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-62731-6_8 · Cited by 18
Pietrofesa, R. A., Chatterjee, S., Park, K., Arguiri, E., Albelda, S. Μ., & Christofidou‐Solomidou, M. (2018) · Antioxidants · doi:10.3390/antiox7030038 · Cited by 20
“In some models of injury, the Nrf2 system has been found to engage in crosstalk with the NLRP3 inflammasome [40,41].”
BackgroundZhang, P., Li, Z., Liang, M., Yuan, J., Zhou, J., Zhang, J., Deng, J., Chen, Y., Tang, H., Xu, C., et al. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02239-3 · Cited by 17
“Interestingly, this alteration is blocked by NLRP3 deletion [15].”
Mahmoud, M. F., Elrashidy, R. A., Mohammed, H. O., Drissi, B., Mahdi, I., & Sobeh, M. (2023) · Journal of Functional Foods · doi:10.1016/j.jff.2023.105641 · Cited by 16
Palomino‐Antolín, A., Decouty‐Pérez, C., Farré‐Alins, V., Narros‐Fernández, P., López-Rodríguez, A. B., Álvarez‐Rubal, M., Valencia, I., Lopez-Munoz, F. J., Ramos, E., Cuadrado, A., et al. (2023) · Antioxidants · doi:10.3390/antiox12091729 · Cited by 16
“It has been recently proposed that a physical interaction of the Nrf2 complex with caspase-1 contributes to the requirement of Nrf2 expression for inflammasome activation [37,38].”
Chen, S.-Y., Xu, H. Z., Qin, Y., He, T., Shi, R., Xing, Y.-R., Xu, J., Cong, R., Wang, M., Yang, J., et al. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113478 · Cited by 15
Zhou, T., Li, Z., & Chen, H. (2022) · Bioengineered · doi:10.1080/21655979.2021.2018981 · Cited by 11
“In addition, one study found a controversial effect of Nrf2 on NLRP3 inflammasome: both Nrf2 abla - tion and Nrf2 activators inhibit activation of NLRP3 inflammasome [23].”
RetractedA Natural Metabolite and Inhibitor of the NLRP3 Inflammasome: 4-hydroxynonenal
Zhang, J., Berk, B. C., & Hsu, C. G. (2024) · Journal of Cellular Immunology · doi:10.33696/immunology.6.192 · Cited by 10
Ebrahim, N. A., Elnagar, M. R., El‐Gamal, R., Habotta, O. A., Albadawi, E. A., Albadrani, M. S., Bahashwan, A. S., & Hassan, H. M. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e38081 · Cited by 15
“Various studies have suggested that melatonin anti-inflammatory and antioxidant effect is through activation of Nrf2 in microglial cells [23,24].”
BackgroundTime‑dependent changes in NLRP3 and Nrf2 levels in lipopolysaccharide‑induced acute lung injury
Dhar, R., Li, N., Zhang, L., Li, Y., Rana, M. N., Hu, Z., Wang, X., Zheng, X., Xu, X., & Tang, H. (2022) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2022.5198 · Cited by 11
“Previous studies have suggested that Nrf2 deficiency contributes to the alleviation NLRP3 expression in acute and chronic inflammatory diseases, and these results demonstrate an unexpected pro‐inflammatory effect of Nrf2 (22,23).”
BackgroundSamanta, S., Mukherjee, G., Chattopadhyay, S., & Bishayi, B. (2025) · The Microbe · doi:10.1016/j.microb.2025.100414 · Cited by 9
Mathew, G., Sharma, A., Pickering, R. J., Rosado, C. J., Lemarie, J., Mudgal, J., Thambi, M., Sebastian, S., Jandeleit-Dahm, K. A. M., de Haan, J. B., et al. (2018) · Free Radical Research · doi:10.1080/10715762.2018.1533636 · Cited by 9
“inflammatory effect of Nrf2 activators [71].”
Sachinvala, N. D., Teramoto, N., & Stergiou, A. (2020) · Brain Sciences · doi:10.3390/brainsci10090600 · Cited by 12
4-Octyl Itaconate Modulates Dendritic Cells Function and Tumor Immunity via NRF2 Activation
Zhu, B., Zhu, L., Ge, Z., Zheng, S., Dai, X., Feng, D., Tan, L., Sha, P., & Yao, Y. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s516085 · Cited by 6
“49 Therefore, the dual role of NRF2 in DCs maturation and cytokine production warrants further investigation.”
Saha, S., Павловна, С. Н., Ленченко, Е. М., Pilshchikova, O., & Muraev, A. A. (2025) · Dentistry Journal · doi:10.3390/dj13070314 · Cited by 6
“It has been shown that Nrf2 directly inhibits the NLRP3-associated genes [35], indicating that Nrf2 may be a therapeutic inhibitor of periodontitis.”
Tomentosin mitigates the LPS induced cardiac injury by regulating Nrf-2/Nf-κβ pathway in mice
Güvenç, M., Aydın, T., Kutlu, T., Etyemez, M., & İşler, C. T. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177589 · Cited by 5
Li, Z., Zhao, P., Fu, J., Qiao, Y., Hou, W., Liu, C., & Min, W. (2025) · Food Bioscience · doi:10.1016/j.fbio.2025.107214 · Cited by 4
Wang, F., Pan, Z., Amona, F. M., Chen, X., Pang, Y., Liang, Y., Lai, M., Zhang, C., Chen, X., & Fang, X. (2025) · Veterinary Research · doi:10.1186/s13567-025-01642-5 · Cited by 4
“Moreover, ROS are important triggering factors for NLRP3 inflammatory vesicle activation, and Nrf2 activation can scavenge ROS and exert antioxidant effects, thus inhibiting the NLRP3 inflammatory vesicle-mediated pyroptosis pathway [79].”
Effects of curcumin and melatonin treatment in the cerebral cortex of adult rats
MUTLU, Ç. Y., Aktan, A. K., & AKBULUT, K. G. (2023) · General Physiology and Biophysics · doi:10.4149/gpb_2022047 · Cited by 6
Ogino, H., Okuno, T., Murano, K., Arakawa, T., & Ueno, H. (2019) · Food and Agricultural Immunology · doi:10.1080/09540105.2018.1547687 · Cited by 3
“motes caspase-1 activity via Nrf2 (Garstkiewicz et al., 2017).”
BackgroundInfluentialThe potential of ginsenosides from Panax ginseng against the NLRP3 inflammasome
Liu, Y., Huang, C., Feng, Y., Zhang, J., Niu, Z., Qi, L., Shen, T., Gao, X., & Hu, W. (2025) · Phytochemistry Reviews · doi:10.1007/s11101-025-10126-5 · Cited by 4
Stein, M., Böttcher, N., Tohidnezhad, M., Fragoulis, A., Bayer, A. U., Klump, H., Baron, J. M., & Pufe, T. (2025) · Journal of Cosmetic Dermatology · doi:10.1111/jocd.70228 · Cited by 2
Mattè, A., Federti, E., Recchiuti, A., Hamza, M., Ferri, G., Riccardi, V., Ceolan, J., Passarini, A., Mazzi, F., Siciliano, A., et al. (2023) · Haematologica · doi:10.3324/haematol.2023.284028 · Cited by 8
Romero-Durán, M. A., Maldonado-Pichardo, M. C., Perez‐Aguilar, J. M., & Aguirre, V. M. B. (2026) · F1000Research · doi:10.12688/f1000research.177148.3 · Cited by 2
The role of CFTR in normal human lung microvascular endothelial cells
Khalaf, M. (2019) · Cited by 1
Chronic sensing of host-derived lipids is an all-in-one signal that primes and activates NLRP3Preprint
Dufies, O., Gioia, M. D., Spreafico, R., Tan, P. J., Springstead, J. R., Prell, S. A., Case, J., Gao, C., Wei, K., Wu, H., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.29.685328 · Cited by 1
Drug Repurposing Patent Applications July–September 2017
Mucke, H. A. (2017) · Assay and Drug Development Technologies · doi:10.1089/adt.2017.29069.pq3
“For the peer review companion article, see Garstkiewicz et al. 21 PubChem CID: 637568 (dimethylfumarate)”
Investigating gender differences in Alzheimer's disease
Fouad, G. I., Ando, H., & Ichihara, G. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877251410204 · Cited by 4
Romero-Durán, M. A., Maldonado-Pichardo, M. C., Perez‐Aguilar, J. M., & Aguirre, V. M. B. (2026) · F1000Research · doi:10.12688/f1000research.177148.1 · Cited by 1
Ergosterol suppresses NLRP3 inflammasome-mediated inflammatory responses through Bmal1
Nguyen, P. L., Liu, B., Lan, S., Pattabiraman, M., & Yu, J. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119466
Romero-Durán, M. A., Maldonado-Pichardo, M. C., Perez‐Aguilar, J. M., & Aguirre, V. M. B. (2026) · F1000Research · doi:10.12688/f1000research.177148.4 · Cited by 1
Oxidative stress and glycosylation in viral infection and inflammatory response
Chakraborty, S., Kasirajan, A., & Pillai, A. B. (2026) · Advances in clinical chemistry · doi:10.1016/bs.acc.2026.08.005
Qin, C.-C., Wang, W.-W., Li, Y.-Q., Tian, Z.-Y., Fan, K.-L., Du, Q.-Y., Ba, T.-J., Zhang, S.-L., Li, G.-C., & Kong, L. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1932000
“This crosstalk is context dependent, as Nrf2 has also been reported to facilitate inflammasome activation under specific experimental conditions (64).”
Metadata
- Authors
- Garstkiewicz, M., Strittmatter, G. E., Grossi, S., Sand, J., Fenini, G., Werner, S., French, L. E., & Beer, H.
- Affiliations
- University Hospital Zurich (CH)
- Institute of Molecular Health Sciences (CH)
- Corresponding author
- Beer, Hans‐Dietmar
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 2017-04-10
- Volume
- 47
- Issue
- 5
- Pages
- 806-817
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W2592459614
- Cited by
- 72
- References
- 44
- Citations by year
- 2026: 7 · 2025: 13 · 2024: 6 · 2023: 5 · 2022: 6 · 2021: 7 · 2020: 10 · 2019: 5 · 2018: 9 · 2017: 4
- FWCI
- 3.13
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Locations
- European Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- Gottfried und Julia Bangerter-Rhyner-Stiftung
- Wilhelm Sander-Stiftung (2015.035.1)
- Promedica Stiftung
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (31003A_132450)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Keywords
- Nrf2, NLRP3 inflammasome, Keap1, dimethyl fumarate, caspase-1, inflammasome activation, Nrf2 degradation, oxidative stress, inflammation, protein-protein interaction, anti-inflammatory agents
- MeSH terms
- Dimethyl Fumarate, NLR Family, Pyrin Domain-Containing 3 Protein, Animals, Gene Expression Regulation, Humans, Inflammation, Signal Transduction, Keratinocytes, Cytokines, Caspase 1, NF-E2-Related Factor 2, Mice, Inflammasomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.